Ziyi Weng

Shanghai, 201318, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications

Correction: An Experimental Analysis of the Molecular Effects of Trastuzumab (Herceptin) and Fulvestrant (Falsodex), as Single Agents or in Combination, on Human HR+/HER2+ Breast Cancer Cell Lines and Mouse Tumor Xenografts.

Correction: An Experimental Analysis of the Molecular Effects of Trastuzumab (Herceptin) and Fulvestrant (Falsodex), as Single Agents or in Combination, on Human HR+/HER2+ Breast Cancer Cell Lines and Mouse Tumor Xenografts.

Journal: PloS one
Published: September 23, 2024

Bioinformatic profiling of prognosis-related genes in the breast cancer immune microenvironment.

Bioinformatic profiling of prognosis-related genes in the breast cancer immune microenvironment.

Journal: Aging
Published: May 13, 2019

Protecting Effects of Gonadotropin-Releasing Hormone Agonist on Chemotherapy-Induced Ovarian Damage in Premenopausal Breast Cancer Patients: A Systematic Review and Meta-Analysis.

Protecting Effects of Gonadotropin-Releasing Hormone Agonist on Chemotherapy-Induced Ovarian Damage in Premenopausal Breast Cancer Patients: A Systematic Review and Meta-Analysis.

Journal: Breast care (Basel, Switzerland)
Published: June 15, 2017

An Experimental Analysis of the Molecular Effects of Trastuzumab (Herceptin) and Fulvestrant (Falsodex), as Single Agents or in Combination, on Human HR+/HER2+ Breast Cancer Cell Lines and Mouse Tumor Xenografts.

An Experimental Analysis of the Molecular Effects of Trastuzumab (Herceptin) and Fulvestrant (Falsodex), as Single Agents or in Combination, on Human HR+/HER2+ Breast Cancer Cell Lines and Mouse Tumor Xenografts.

Journal: PloS one
Published: September 22, 2016

Increased chemosensitivity and radiosensitivity of human breast cancer cell lines treated with novel functionalized single-walled carbon nanotubes.

Increased chemosensitivity and radiosensitivity of human breast cancer cell lines treated with novel functionalized single-walled carbon nanotubes.

Journal: Oncology letters
Published: June 28, 2015

Synuclein γ compromises spindle assembly checkpoint and renders resistance to antimicrotubule drugs.

Synuclein γ compromises spindle assembly checkpoint and renders resistance to antimicrotubule drugs.

Journal: Molecular cancer therapeutics
Published: January 17, 2014

Oxygen-carbon nanotubes as a chemotherapy sensitizer for paclitaxel in breast cancer treatment.

Oxygen-carbon nanotubes as a chemotherapy sensitizer for paclitaxel in breast cancer treatment.

Journal: PloS one
Published: November 07, 2013

Expression of synuclein gamma indicates poor prognosis of triple-negative breast cancer.

Expression of synuclein gamma indicates poor prognosis of triple-negative breast cancer.

Journal: Medical oncology (Northwood, London, England)
Published: March 18, 2013
Showing 1-8 of 8

Last Updated: 09/26/2026